Intravenous infusion or subcutaneous injection, casirivimab and imdevimab, includes infusion or injection, and post administration monitoring in the home or residence. This includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency, subsequent repeat doses
| Insurance Carrier | Facility/Professional | Modifier | Low Price | Median Price | High Price |
|---|---|---|---|---|---|
Cigna
| Facility | $750.00 | $750.00 | $750.00 | |
Cigna
| Professional | $750.00 | $750.00 | $937.50 | |
Midlands
| Facility | $921.28 | $1,125.18 | $1,330.61 | |
Midlands
| Professional | $900.75 | $1,177.71 | $1,637.38 |